Myung Jin Oh, Unyoung Kim, Youngsuk Seo, Hyun Joo An
언어
영어(ENG)
URL
https://www.earticle.net/Article/A294786
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
The glycosyl modification on protein therapeutics is considered to be a very important attribute due to its strong effect on quality, safety, and potency. Thus, systematic approach is absolutely required for measurement and control of glycosylation from the drug development to post-approval batch release. We have developed stepwise strategies for glycome quality assessment during drug design and manufacture in the level of intact protein, glycopeptide, and glycan. Intact protein analysis was employed for detailed characterization of highly complex micro—heterogeneity, including various glycofrom profiles by high-resolution native mass spectrometry. Site-specific glycosylation with micro & macro glycan heterogeneity can be achieved by glycopeptide analysis which combines molecular size fractionation, multiple proteolysis, and PGC nanoLC MS/MS. This approach could be widely applied for high-quality analytical characterization of glycosylation, starting from early drug development to final lot releas.
저자
Myung Jin Oh [ 오명진 | Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Korea ]
Unyoung Kim [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Korea ]
Youngsuk Seo [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Korea ]
Hyun Joo An [ Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Korea ]
본 학회는 화학, 생화학, 분자생물학, 미생물학, 식품공학, 의학, 약학, 유전공학 및 생물공학, 환경 및 기타 공업 등 전 분야의 탄수화물관련 이론과 기술을 연구 발전시키고 산학협동을 통해 이를 보급하여 국내 관련 산업의 발전 및 국민생활의 과학화에 기여하고자 하며, 이러한 목표와 비젼의 실현을 위해 회원들이 적극적인 참여와 활동을 전개하고자 한다.